Hologic Inc News Today

(Sharecast News) - US stocks finished in a mixed fashion on Tuesday with the Dow falling but the Nasdaq putting in decent gains, helped by a strong performance from tech heavyweight Apple.

/PRNewswire/ -- DelveInsights Anti-Radiation Drugs Market Insights report provides the current and forecast market analysis, individual leading anti-radiation...

The rise in demand for anti-radiation drugs is mainly driven by several factors. These include the growing occurrence of side effects linked to cancer screening methods, heightened risks of

Public Employees Retirement Association of Colorado increased its stake in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 2,257.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 214,962 shares of the medical equipment provider’s stock after purchasing an […]

Market OverviewThe Global Radiofrequency Ablation Devices Market is set for substantial growth over the next decade, driven by several key factors. In 2023, the market was valued at USD 4.8 billion, and projections indicate it will reach approximately USD 12.5 billion by 2032. This represents a compound annual growt...

Assetmark Inc. lessened its holdings in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 68.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,496 shares of the medical equipment provider’s stock after selling 14,000 shares during the quarter. Assetmark Inc.’s holdings in Hologic […]

CHICAGO, May 29, 2024 /PRNewswire/ -- Clinical Microbiology Market in terms of revenue was estimated to be worth $5.0 billion in 2024 and is poised to reach $6.9 billion by 2029, growing at

Nomura Asset Management Co. Ltd. lowered its holdings in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 26.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 98,197 shares of the medical equipment provider’s stock after selling 35,894 shares during the quarter. Nomura Asset Management Co. […]

The "Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), and End User

Boston Family Office LLC lessened its position in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 1.3% in the fourth quarter, Holdings Channel.com reports. The fund owned 19,598 shares of the medical equipment provider’s stock after selling 249 shares during the quarter. Boston Family Office LLC’s holdings in Hologic were worth $1,400,000 at the […]